Siddiqi SM - Search Results

1

Antiviral enantiomeric preference for 5'-noraristeromycin.

Siddiqi SM, Chen X, Schneller SW, Ikeda S, Snoeck R, Andrei G, Balzarini J, De Clercq E. Siddiqi SM, et al. J Med Chem. 1994 Feb 18;37(4):551-4. doi: 10.1021/jm00030a014. J Med Chem. 1994. PMID: 8120872

2

3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties.

Siddiqi SM, Chen X, Rao J, Schneller SW, Ikeda S, Snoeck R, Andrei G, Balzarini J, De Clercq E. Siddiqi SM, et al. J Med Chem. 1995 Mar 17;38(6):1035-8. doi: 10.1021/jm00006a023. J Med Chem. 1995. PMID: 7699695

3

An epimer of 5'-noraristeromycin and its antiviral properties.

Siddiqi SM, Chen X, Schneller SW, Ikeda S, Snoeck R, Andrei G, Balzarini J, De Clercq E. Siddiqi SM, et al. J Med Chem. 1994 Apr 29;37(9):1382-4. doi: 10.1021/jm00035a020. J Med Chem. 1994. PMID: 8176716

4

Synthesis and antiviral properties of carbocyclic 3'-oxa-2',3'-dideoxyguanosine and its 7-deazaguanosine analogue.

Chen X, Siddiqi SM, Schneller SW, Snoeck R, Balzarini J, De Clercq E. Chen X, et al. Among authors: siddiqi sm. Antiviral Res. 1993 Apr;20(4):333-45. doi: 10.1016/0166-3542(93)90076-u. Antiviral Res. 1993. PMID: 8387261

5

Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.

Siddiqi SM, Jacobson KA, Esker JL, Olah ME, Ji XD, Melman N, Tiwari KN, Secrist JA 3rd, Schneller SW, Cristalli G, et al. Siddiqi SM, et al. J Med Chem. 1995 Mar 31;38(7):1174-88. doi: 10.1021/jm00007a014. J Med Chem. 1995. PMID: 7707320 Free PMC article.

6

Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.

Jacobson KA, Siddiqi SM, Olah ME, Ji XD, Melman N, Bellamkonda K, Meshulam Y, Stiles GL, Kim HO. Jacobson KA, et al. Among authors: siddiqi sm. J Med Chem. 1995 May 12;38(10):1720-35. doi: 10.1021/jm00010a017. J Med Chem. 1995. PMID: 7752196 Free PMC article.

7

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Kim HO, Ji XD, Siddiqi SM, Olah ME, Stiles GL, Jacobson KA. Kim HO, et al. Among authors: siddiqi sm. J Med Chem. 1994 Oct 14;37(21):3614-21. doi: 10.1021/jm00047a018. J Med Chem. 1994. PMID: 7932588 Free PMC article.

8

Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.

van Rhee AM, Siddiqi SM, Melman N, Shi D, Padgett WL, Daly JW, Jacobson KA. van Rhee AM, et al. Among authors: siddiqi sm. J Med Chem. 1996 Jan 19;39(2):398-406. doi: 10.1021/jm9504823. J Med Chem. 1996. PMID: 8558508 Free PMC article.

9

Comparative molecular field analysis of selective A3 adenosine receptor agonists.

Siddiqi SM, Pearlstein RA, Sanders LH, Jacobson KA. Siddiqi SM, et al. Bioorg Med Chem. 1995 Oct;3(10):1331-43. doi: 10.1016/0968-0896(95)00116-x. Bioorg Med Chem. 1995. PMID: 8564399 Free PMC article.

10

A₃-adenosine receptors: design of selective ligands and therapeutic prospects.

Jacobson KA, Kim HO, Siddiqi SM, Olah ME, Stiles GL, von Lubitz DK. Jacobson KA, et al. Among authors: siddiqi sm. Drugs Future. 1995 Jul;20(7):689-699. doi: 10.1358/dof.1995.020.07.531583. Drugs Future. 1995. PMID: 25242859 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters